Zacks: Brokerages Expect Nu Skin Enterprises, Inc. (NYSE:NUS) Will Post Earnings of $0.82 Per Share

Analysts expect Nu Skin Enterprises, Inc. (NYSE:NUSGet Rating) to report earnings per share (EPS) of $0.82 for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Nu Skin Enterprises’ earnings, with the lowest EPS estimate coming in at $0.78 and the highest estimate coming in at $0.85. Nu Skin Enterprises posted earnings of $1.15 per share in the same quarter last year, which indicates a negative year-over-year growth rate of 28.7%. The company is expected to issue its next quarterly earnings results on Monday, January 1st.

According to Zacks, analysts expect that Nu Skin Enterprises will report full year earnings of $3.80 per share for the current year, with EPS estimates ranging from $3.73 to $3.85. For the next fiscal year, analysts anticipate that the company will report earnings of $4.09 per share, with EPS estimates ranging from $4.05 to $4.12. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for Nu Skin Enterprises.

Nu Skin Enterprises (NYSE:NUSGet Rating) last posted its earnings results on Wednesday, May 4th. The company reported $0.76 earnings per share for the quarter, topping the consensus estimate of $0.73 by $0.03. The firm had revenue of $604.90 million during the quarter, compared to analysts’ expectations of $579.70 million. Nu Skin Enterprises had a return on equity of 22.05% and a net margin of 5.28%. The firm’s revenue was down 10.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.91 earnings per share.

Several analysts have recently weighed in on NUS shares. Zacks Investment Research raised Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 target price for the company in a report on Tuesday, March 29th. Jefferies Financial Group lifted their target price on shares of Nu Skin Enterprises from $61.00 to $75.00 in a report on Thursday, February 17th. TheStreet downgraded shares of Nu Skin Enterprises from a “b” rating to a “c+” rating in a research report on Friday, February 18th. DA Davidson upped their target price on shares of Nu Skin Enterprises from $47.00 to $50.00 and gave the company a “neutral” rating in a report on Thursday, February 17th. Finally, StockNews.com lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Friday, May 13th. Three analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, Nu Skin Enterprises presently has a consensus rating of “Buy” and an average target price of $60.60.

Shares of NUS opened at $47.19 on Friday. The firm has a fifty day moving average price of $46.48 and a 200 day moving average price of $48.06. The stock has a market cap of $2.37 billion, a PE ratio of 17.48 and a beta of 1.23. Nu Skin Enterprises has a 1-year low of $39.40 and a 1-year high of $62.70. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.72 and a quick ratio of 0.95.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 8th. Shareholders of record on Friday, May 27th will be paid a $0.385 dividend. The ex-dividend date is Thursday, May 26th. This represents a $1.54 annualized dividend and a yield of 3.26%. Nu Skin Enterprises’s dividend payout ratio is currently 57.04%.

In other Nu Skin Enterprises news, CEO Ryan S. Napierski sold 25,000 shares of the business’s stock in a transaction on Wednesday, May 25th. The shares were sold at an average price of $44.91, for a total value of $1,122,750.00. Following the transaction, the chief executive officer now directly owns 122,683 shares of the company’s stock, valued at approximately $5,509,693.53. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrew D. Lipman sold 1,000 shares of the business’s stock in a transaction on Tuesday, March 22nd. The shares were sold at an average price of $47.40, for a total transaction of $47,400.00. The disclosure for this sale can be found here. Insiders sold a total of 66,125 shares of company stock worth $3,009,855 over the last three months. 2.80% of the stock is currently owned by corporate insiders.

Large investors have recently bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in shares of Nu Skin Enterprises by 62.9% during the 4th quarter. JPMorgan Chase & Co. now owns 295,510 shares of the company’s stock worth $14,997,000 after purchasing an additional 114,061 shares during the period. Geode Capital Management LLC grew its stake in Nu Skin Enterprises by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 894,968 shares of the company’s stock valued at $36,219,000 after acquiring an additional 17,566 shares during the last quarter. Exchange Traded Concepts LLC grew its stake in Nu Skin Enterprises by 3.5% in the 4th quarter. Exchange Traded Concepts LLC now owns 11,724 shares of the company’s stock valued at $595,000 after acquiring an additional 396 shares during the last quarter. Meritage Portfolio Management acquired a new stake in Nu Skin Enterprises in the 4th quarter valued at about $219,000. Finally, Yousif Capital Management LLC acquired a new stake in Nu Skin Enterprises in the 4th quarter valued at about $1,417,000. 93.79% of the stock is currently owned by institutional investors and hedge funds.

Nu Skin Enterprises Company Profile (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Featured Articles

Get a free copy of the Zacks research report on Nu Skin Enterprises (NUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.